Skip to main content
SpringerPlus

Table 7 Median and mean activity loss scores for EPO versus no EPO therapy

From: Assessment of physical activity in patients with chronic kidney disease and renal replacement therapy

Group

Median TAS (IQR)

Mean TAS (SD)

p value

EPO therapy

8 (7–10)

7.84 (2.25)

0.013

No EPO therapy

9 (7–11)

9.15 (2.45)

 
  1. Median and mean activity loss scores were calculated for patients currently receiving EPO therapy for their CKD-induced anaemia and compared to those who did not require EPO therapy
Back to article page